Product Liability · Claims Closed — Awaiting Final Approval

Roundup Cancer Settlement Program Status

Published July 9, 2026
Updated September 17, 2026

This Roundup litigation update tracks the proposed nationwide compensation program and separate individual lawsuits.

Roundup Cancer Settlement Program Status

Current Status

The final-approval hearing in the proposed nationwide Roundup class settlement was held on September 14, 2026 before Judge Timothy J. Boyer in the 22nd Judicial Circuit Court in St. Louis, after being rescheduled twice — from July 9 to August 19, 2026, and then by an August 6, 2026 order. The court did not rule from the bench; it invited further filings from both supporters and objectors before deciding whether to approve the deal. No final-approval order has been entered, registration and claim filing remain closed until one is, and the deadline to opt out passed on August 21, 2026. Separately, the Supreme Court narrowed the legal theory behind most Roundup cancer claims in June 2026, which is covered below.

StatusAwaiting final-approval order
Claim DeadlineCurrent registration period closed
Settlement ValueUp to $7.25 billion
Current MilestoneHearing held September 14, 2026Judge took the matter under advisement; no order entered

What Is This Case About?

Plaintiffs allege that exposure to Roundup and other glyphosate-based weed killers caused non-Hodgkin lymphoma and that Monsanto failed to warn users of the risk. Monsanto and its parent Bayer deny the allegations and deny liability, and the proposed settlement is expressly not an admission of wrongdoing. The settlement was filed on February 17, 2026 as Randall King et al. v. Monsanto Co., No. 2622-CC00325, in the 22nd Judicial Circuit Court for the City of St. Louis, Missouri, and the court granted preliminary approval on March 4, 2026.

Who Is Covered?

The proposed class reaches far beyond the roughly 65,000 Roundup claims already on file. It covers people in the United States exposed to Roundup or other glyphosate-based weed killers before February 17, 2026, and it includes a "futures" group — people who were exposed but have not been diagnosed with non-Hodgkin lymphoma, and who would be able to claim later if they ever are. That breadth is the reason several plaintiffs' firms objected: it sweeps in people who have not yet been harmed and who are not currently in litigation.

What Benefits Would Be Available?

Monsanto would pay up to $7.25 billion, structured in tiers and funded on a declining annual schedule over roughly 17 to 21 years rather than as a single lump sum. Reported individual awards run into the range of about $165,000 at the top tier, with the amount driven by whether exposure was occupational or residential, age at diagnosis and the lymphoma subtype. Nothing is payable until the court grants final approval and any appeals are resolved. Class members already diagnosed before February 17, 2026 would have 180 days from final approval to register, and those diagnosed later would have a further window tied to the date of diagnosis.

What the Supreme Court Changed

On June 25, 2026 the Supreme Court decided Monsanto Co. v. Durnell, No. 24–1068, holding 7–2 that the Federal Insecticide, Fungicide, and Rodenticide Act expressly preempts state-law failure-to-warn claims that would require a cancer warning the EPA-approved label does not. Justice Kavanaugh wrote for the majority; Justice Jackson dissented, joined by Justice Gorsuch. The Missouri Court of Appeals judgment was reversed and remanded. The decision does not resolve the class settlement, but it removed the central theory behind most Roundup cancer verdicts, which is part of the backdrop against which the settlement is being weighed. Our fuller write-up is on the Supreme Court Roundup decision page.

What Happens Next?

Judge Boyer has the fairness question under advisement after the September 14, 2026 hearing and has not said when he will rule. If he approves the settlement, registration opens and the appeal period begins; if he rejects it, the parties return to litigating the underlying claims. Individual Roundup lawsuits, including those in the federal Roundup MDL 2741 proceeding, continue outside this class process.

Official Information

Review the latest information on the Roundup class settlement website website.

Settlement Value Up to $7.25 billion
Case Title Randall King et al. v. Monsanto Co.
Case Number 2622-CC00325
Court or Forum 22nd Judicial Circuit Court, City of St. Louis, Missouri
Current Milestone Final-approval hearing held September 14, 2026; no order entered
For more class actions, recalls, and refunds, keep scrolling below.

More Open Consumer Settlements